Eton Pharmaceuticals Stock (NASDAQ: ETON) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 62.405K |
Day Range | - - - |
52 Wk Range | 2.420 - 5.810 |
Market Cap | $78.605M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 0.91% |
Days to Cover | 2.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eton Pharmaceuticals (NASDAQ: ETON) through any online brokerage.
Other companies in Eton Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP), Marinus Pharma (NASDAQ:MRNS) and Anebulo Pharmaceuticals (NASDAQ:ANEB).
The latest price target for Eton Pharmaceuticals (NASDAQ: ETON) was reported by HC Wainwright & Co. on Monday, December 11, 2023. The analyst firm set a price target for 10.00 expecting ETON to rise to within 12 months (a possible 226.80% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Eton Pharmaceuticals (NASDAQ: ETON) is $3.06 last updated April 17, 2024 at 4:05 PM EDT.
There are no upcoming dividends for Eton Pharmaceuticals.
Eton Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Eton Pharmaceuticals.
Eton Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.